MedPath

Effect of probiotic in gestational diabetes

Phase 2
Completed
Conditions
gestatinal diabetes mellitus.
Diabetes mellitus in pregnancy, unspecified
Registration Number
IRCT2016110111020N6
Lead Sponsor
Vice chancellor for research, Tehran University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
542
Inclusion Criteria

singleton pregnant women in the first trimester; BMI more than 25; family history in the first-degree relatives; history of GDM in previous pregnancy; ovarian poly cystic syndrome; history of IUFD birth; Macrosomia; abortion
Exclusion criteria: diabetes; heart and CNS diseases; using nerve drugs; multiple pregnancy; positive result of 75 grams glucose test in the first visit

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gestational diabetes. Timepoint: 24- 28 weeks of pregnancy. Method of measurement: glucose tolerance test.
Secondary Outcome Measures
NameTimeMethod
Type of delivery. Timepoint: end of pregnancy. Method of measurement: observational.;Macrosomia. Timepoint: After child birth. Method of measurement: weighting.;Preeclampsia. Timepoint: during pregnancy. Method of measurement: measuring blood pressure and proteinuria.
© Copyright 2025. All Rights Reserved by MedPath